ERDERA Clinical Trial Call – Model Award Agreement

Yes
Model award agreement document setting out the structure, articles and contractual provisions applicable to funded activities.

Structured contractual document containing articles, definitions, terms and conditions, and annexes related to the implementation of funded activities. The source includes a table of contents and agreement clauses but does not provide sufficient readable publication-style content to extract a more detailed summary without introducing information that is not explicitly supported by the document.

V1 – 22/09/2026

You might also be interested in

November 25 @ 1:00 pm - 2:00 pm
Intended for clinicians, clinical geneticists, researchers, data analysts and ERN members working in rare diseases
December 4 @ 12:00 pm - 1:00 pm
Understanding the ethical concerns of AI in rare disease research and the principles of trustworthy AI
At the World Orphan Drug Congress Europe 2026 in Amsterdam, ERDERA contributed to discussions on artificial intelligence, clinical trials, emerging therapies and the future of rare disease research, including an interactive workshop on the responsible use of AI
Horizon Europe’s 2026–2027 work programme combines broad health research opportunities with changes to applications and new support for taking existing results further.